HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gi-Young Kim Selected Research

muconomycin A

9/2013Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
5/2013Verrucarin A enhances TRAIL-induced apoptosis via NF-κB-mediated Fas overexpression.
2/2013Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gi-Young Kim Research Topics

Disease

128Neoplasms (Cancer)
06/2022 - 08/2003
41Leukemia
01/2021 - 06/2005
28Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 11/2007
25Carcinoma (Carcinomatosis)
01/2021 - 07/2009
23Hepatocellular Carcinoma (Hepatoma)
10/2021 - 10/2008
22Inflammation (Inflammations)
09/2021 - 10/2003
17Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 01/2012
14Neoplasm Metastasis (Metastasis)
03/2020 - 12/2003
9Breast Neoplasms (Breast Cancer)
01/2021 - 01/2008
8Prostatic Neoplasms (Prostate Cancer)
07/2014 - 09/2010
6Bone Resorption
02/2022 - 12/2017
6Melanoma (Melanoma, Malignant)
07/2021 - 12/2019
6Adenocarcinoma
05/2011 - 11/2007
5Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 07/2013
5Septic Shock (Toxic Shock Syndrome)
04/2021 - 10/2003
5Necrosis
01/2021 - 06/2011
5Asthma (Bronchial Asthma)
12/2019 - 04/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016 - 06/2007
4Skin Diseases (Skin Disease)
09/2022 - 09/2013
4Osteoporosis
10/2021 - 11/2019
4Rheumatoid Arthritis
05/2021 - 09/2007
4Osteoarthritis
10/2017 - 12/2015
3Hypertrophy
01/2022 - 12/2019
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 04/2011
3Shock
01/2021 - 03/2006
3Experimental Arthritis
02/2020 - 06/2003
3Chronic Disease (Chronic Diseases)
01/2017 - 06/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2015 - 12/2011
3Lung Neoplasms (Lung Cancer)
06/2013 - 02/2011

Drug/Important Bio-Agent (IBA)

32Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 10/2003
24Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 01/2008
23CaspasesIBA
05/2022 - 06/2005
21LigandsIBA
06/2019 - 05/2007
16CytokinesIBA
05/2021 - 10/2003
15Matrix Metalloproteinases (MMPs)IBA
06/2022 - 02/2009
15LipopolysaccharidesIBA
05/2021 - 10/2003
14Ethanol (Ethyl Alcohol)IBA
06/2022 - 08/2009
14Proteins (Proteins, Gene)FDA Link
11/2019 - 06/2008
12AntioxidantsIBA
07/2021 - 06/2007
11Caspase 3 (Caspase-3)IBA
01/2020 - 05/2007
11Telomerase (Telomerase Reverse Transcriptase)IBA
01/2017 - 03/2008
11NF-kappa B (NF-kB)IBA
11/2016 - 06/2007
10Biological ProductsIBA
10/2021 - 08/2003
10cordycepinIBA
01/2019 - 12/2010
9Cytochromes c (Cytochrome c)IBA
01/2022 - 03/2008
8AlkaloidsIBA
01/2021 - 01/2008
8Pharmaceutical PreparationsIBA
09/2020 - 10/2009
8Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2018 - 10/2010
8DNA (Deoxyribonucleic Acid)IBA
10/2016 - 03/2008
7sulforaphaneIBA
09/2020 - 05/2007
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 02/2009
6Transcription Factors (Transcription Factor)IBA
10/2021 - 02/2010
6FlavonoidsIBA
07/2021 - 12/2008
6TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021 - 01/2011
6fucoidanIBA
05/2017 - 04/2011
6sanguinarineIBA
01/2016 - 01/2008
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019 - 02/2009
5buteinIBA
02/2018 - 12/2009
5CurcuminIBA
05/2010 - 06/2005
4fisetinIBA
01/2022 - 01/2020
4CateninsIBA
10/2021 - 01/2020
4Auranofin (Ridaura)FDA Link
05/2021 - 04/2017
4Therapeutic UsesIBA
02/2020 - 05/2012
4Caspase 9IBA
01/2020 - 03/2009
4GenisteinIBA
08/2019 - 11/2007
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2019 - 11/2014
4baicaleinIBA
01/2019 - 03/2016
4Dinoprostone (PGE2)FDA Link
10/2018 - 06/2007
4Messenger RNA (mRNA)IBA
01/2017 - 09/2009
4Antineoplastic Agents (Antineoplastics)IBA
07/2014 - 04/2012
4Proteoglycans (Proteoglycan)IBA
09/2005 - 06/2003
3bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
11/2021 - 01/2011
3JNK Mitogen-Activated Protein KinasesIBA
10/2021 - 06/2010
3Retinaldehyde (Retinal)IBA
09/2021 - 01/2021
3SpermidineIBA
09/2021 - 03/2018
3Particulate MatterIBA
08/2021 - 07/2020
3Melanocyte-Stimulating Hormones (MSH)IBA
07/2021 - 01/2020
3Melanins (Melanin)IBA
07/2021 - 01/2020
3TriterpenesIBA
01/2021 - 06/2008
3coptisineIBA
01/2021 - 07/2020
3PolyphenolsIBA
01/2020 - 12/2009
3pyrazolanthroneIBA
11/2019 - 03/2008
3Adenosine Triphosphate (ATP)IBA
04/2019 - 01/2019
33,3',4,5'-tetrahydroxystilbeneIBA
01/2018 - 04/2011
3isothiocyanic acidIBA
01/2018 - 09/2010
3InterleukinsIBA
10/2017 - 10/2007
3Glutamine (L-Glutamine)FDA Link
01/2017 - 03/2006
3Methanol (Carbinol)IBA
06/2016 - 01/2012
3Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2014 - 06/2011
3muconomycin AIBA
09/2013 - 02/2013
3MethyltransferasesIBA
05/2013 - 09/2012
3DecitabineFDA Link
05/2013 - 09/2012
3A-Form DNA (A-DNA)IBA
05/2013 - 09/2012
3diallyl disulfide (diallyl disulphide)IBA
11/2012 - 09/2010
3Phosphotransferases (Kinase)IBA
07/2011 - 12/2008
3GossypolIBA
04/2011 - 06/2008

Therapy/Procedure

12Therapeutics
01/2021 - 10/2008
8Traditional Medicine (Folk Remedies)
03/2020 - 08/2006
6Oral Administration
08/2021 - 06/2003
5Drug Therapy (Chemotherapy)
06/2008 - 01/2007